Catalent aims to boost drug delivery through industry-academia partnership

Boosting communication between industry and academia is the way to advance drug delivery, says Catalent
Boosting communication between industry and academia is the way to advance drug delivery, says Catalent
Catalent has established a new institute in a bid to advance drug delivery by creating links between industry and academia.

The association – named the Applied Drug Delivery Institute – will provide training programmes, help establish partnerships between universities and business, and will work with regulatory bodies in an effort to solve industry-wide issues.

In a statement, senior VP of research and development (R&D) Kurt Nielsen said: “The mission of the Catalent Applied Drug Delivery Institute is to bring better treatments to market by advancing the development and adoption of applied drug delivery technologies.

Rao Tatapudy, VP of scientific affairs added: “We look forward to a continuous series of successful collaborations as the institute’s activities unfold.”

The firm launched the new organisation during a press conference at AAPS, where we spoke to the programme leaders about the reasons behind the move, the current happenings and what’s to come.

Read the article on next week’s Outsourcing-Pharma.com

Related news

Show more

Related products

show more

Powered by Ingredients + Innovation

Powered by Ingredients + Innovation

Content provided by Univar Solutions USA | 07-Oct-2024 | Product Brochure

In partnership with our industry-leading supplier partners, Univar Solutions Pharmaceutical Ingredients is proud to introduce Powering Healthy Tomorrows.

Reliability, scale, and security of supply

Reliability, scale, and security of supply

Content provided by Univar Solutions USA | 28-Aug-2024 | Product Brochure

Univar Solutions Pharmaceutical Ingredients is proud to offer one of the most expansive portfolios of 15,000+ products, including high-purity solvents,...

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Related suppliers

Follow us

Products

View more

Webinars